GO ID
|
Source
|
Type
|
Description
|
GO:0072562 |
IEA:Ensembl
|
C
|
blood microparticle
|
GO:0042627 |
IEA:UniProtKB-KW
|
C
|
chylomicron
|
GO:0070062 |
IEA:Ensembl
|
C
|
extracellular vesicular exosome
|
GO:0034364 |
IEA:UniProtKB-KW
|
C
|
high-density lipoprotein particle
|
GO:0034363 |
IEA:Ensembl
|
C
|
intermediate-density lipoprotein particle
|
GO:0005634 |
IEA:Ensembl
|
C
|
nucleus
|
GO:0034361 |
IEA:UniProtKB-KW
|
C
|
very-low-density lipoprotein particle
|
GO:0016209 |
IEA:Ensembl
|
F
|
antioxidant activity
|
GO:0001540 |
IEA:Ensembl
|
F
|
beta-amyloid binding
|
GO:0017127 |
IEA:Ensembl
|
F
|
cholesterol transporter activity
|
GO:0008201 |
IEA:UniProtKB-KW
|
F
|
heparin binding
|
GO:0008289 |
IEA:Ensembl
|
F
|
lipid binding
|
GO:0071813 |
IEA:Ensembl
|
F
|
lipoprotein particle binding
|
GO:0046911 |
IEA:Ensembl
|
F
|
metal chelating activity
|
GO:0007186 |
IEA:Ensembl
|
P
|
G-protein coupled receptor signaling pathway
|
GO:0097114 |
IEA:Ensembl
|
P
|
N-methyl-D-aspartate receptor clustering
|
GO:0097113 |
IEA:Ensembl
|
P
|
alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor clustering
|
GO:0048844 |
IEA:Ensembl
|
P
|
artery morphogenesis
|
GO:0019934 |
IEA:Ensembl
|
P
|
cGMP-mediated signaling
|
GO:0006874 |
IEA:Ensembl
|
P
|
cellular calcium ion homeostasis
|
GO:0006707 |
IEA:Ensembl
|
P
|
cholesterol catabolic process
|
GO:0033344 |
IEA:Ensembl
|
P
|
cholesterol efflux
|
GO:0042632 |
IEA:Ensembl
|
P
|
cholesterol homeostasis
|
GO:0034382 |
IEA:Ensembl
|
P
|
chylomicron remnant clearance
|
GO:0055089 |
IEA:Ensembl
|
P
|
fatty acid homeostasis
|
GO:0034380 |
IEA:Ensembl
|
P
|
high-density lipoprotein particle assembly
|
GO:0034384 |
IEA:Ensembl
|
P
|
high-density lipoprotein particle clearance
|
GO:0034375 |
IEA:Ensembl
|
P
|
high-density lipoprotein particle remodeling
|
GO:0042158 |
IEA:Ensembl
|
P
|
lipoprotein biosynthetic process
|
GO:0042159 |
IEA:Ensembl
|
P
|
lipoprotein catabolic process
|
GO:0015909 |
IEA:Ensembl
|
P
|
long-chain fatty acid transport
|
GO:0034374 |
IEA:Ensembl
|
P
|
low-density lipoprotein particle remodeling
|
GO:0051651 |
IEA:Ensembl
|
P
|
maintenance of location in cell
|
GO:0043407 |
IEA:Ensembl
|
P
|
negative regulation of MAP kinase activity
|
GO:1902430 |
IEA:Ensembl
|
P
|
negative regulation of beta-amyloid formation
|
GO:0043537 |
IEA:Ensembl
|
P
|
negative regulation of blood vessel endothelial cell migration
|
GO:0045541 |
IEA:Ensembl
|
P
|
negative regulation of cholesterol biosynthetic process
|
GO:0090370 |
IEA:Ensembl
|
P
|
negative regulation of cholesterol efflux
|
GO:0061000 |
IEA:Ensembl
|
P
|
negative regulation of dendritic spine development
|
GO:1902951 |
IEA:Ensembl
|
P
|
negative regulation of dendritic spine maintenance
|
GO:0001937 |
IEA:Ensembl
|
P
|
negative regulation of endothelial cell proliferation
|
GO:0050728 |
IEA:Ensembl
|
P
|
negative regulation of inflammatory response
|
GO:1903001 |
IEA:Ensembl
|
P
|
negative regulation of lipid transport across blood brain barrier
|
GO:1901215 |
IEA:Ensembl
|
P
|
negative regulation of neuron death
|
GO:1902999 |
IEA:Ensembl
|
P
|
negative regulation of phospholipid efflux
|
GO:0010544 |
IEA:Ensembl
|
P
|
negative regulation of platelet activation
|
GO:1901627 |
IEA:Ensembl
|
P
|
negative regulation of postsynaptic membrane organization
|
GO:1901630 |
IEA:Ensembl
|
P
|
negative regulation of presynaptic membrane organization
|
GO:0007263 |
IEA:Ensembl
|
P
|
nitric oxide mediated signal transduction
|
GO:0033700 |
IEA:Ensembl
|
P
|
phospholipid efflux
|
GO:1902004 |
IEA:Ensembl
|
P
|
positive regulation of beta-amyloid formation
|
GO:0030828 |
IEA:Ensembl
|
P
|
positive regulation of cGMP biosynthetic process
|
GO:0010875 |
IEA:Ensembl
|
P
|
positive regulation of cholesterol efflux
|
GO:0060999 |
IEA:Ensembl
|
P
|
positive regulation of dendritic spine development
|
GO:1902952 |
IEA:Ensembl
|
P
|
positive regulation of dendritic spine maintenance
|
GO:0046889 |
IEA:Ensembl
|
P
|
positive regulation of lipid biosynthetic process
|
GO:1903002 |
IEA:Ensembl
|
P
|
positive regulation of lipid transport across blood brain barrier
|
GO:0032805 |
IEA:Ensembl
|
P
|
positive regulation of low-density lipoprotein particle receptor catabolic process
|
GO:0051044 |
IEA:Ensembl
|
P
|
positive regulation of membrane protein ectodomain proteolysis
|
GO:1902998 |
IEA:Ensembl
|
P
|
positive regulation of neurofibrillary tangle assembly
|
GO:1901216 |
IEA:Ensembl
|
P
|
positive regulation of neuron death
|
GO:0051000 |
IEA:Ensembl
|
P
|
positive regulation of nitric-oxide synthase activity
|
GO:1902995 |
IEA:Ensembl
|
P
|
positive regulation of phospholipid efflux
|
GO:1901628 |
IEA:Ensembl
|
P
|
positive regulation of postsynaptic membrane organization
|
GO:1901631 |
IEA:Ensembl
|
P
|
positive regulation of presynaptic membrane organization
|
GO:0017038 |
IEA:Ensembl
|
P
|
protein import
|
GO:0006898 |
IEA:Ensembl
|
P
|
receptor-mediated endocytosis
|
GO:0032489 |
IEA:Ensembl
|
P
|
regulation of Cdc42 protein signal transduction
|
GO:1900221 |
IEA:Ensembl
|
P
|
regulation of beta-amyloid clearance
|
GO:1902947 |
IEA:Ensembl
|
P
|
regulation of tau-protein kinase activity
|
GO:0002021 |
IEA:Ensembl
|
P
|
response to dietary excess
|
GO:0006979 |
IEA:Ensembl
|
P
|
response to oxidative stress
|
GO:0043691 |
IEA:Ensembl
|
P
|
reverse cholesterol transport
|
GO:0006641 |
IEA:Ensembl
|
P
|
triglyceride metabolic process
|
GO:0042311 |
IEA:Ensembl
|
P
|
vasodilation
|
GO:0034447 |
IEA:Ensembl
|
P
|
very-low-density lipoprotein particle clearance
|